Effects of FGF-2 and OP-1 in vitro on donor source cartilage for auricular reconstruction tissue engineering.
Abstract
[OBJECTIVE] Microtia is a congenital partial or total loss of the external ear with current treatment approaches involving autologous construction from costal cartilage. Alternatively, tissue engineering provides possible use of normal or microtia auricular chondrocytes harvested from patients. This study investigated effects in vitro of basic fibroblast growth factor (FGF-2) and osteogenic protein 1 (OP-1) on human pediatric normal and microtia auricular chondrocytes and their potential proliferation and differentiation for cellular expansion. A working hypothesis was that FGF-2 promotes proliferation and OP-1 maintains an auricular phenotype of these cells.
[METHODS] Two patients, one undergoing otoplasty and one an ear construction, yielded normal and microtia auricular chondrocytes, respectively. The two donor sets of isolated chondrocytes were equally divided into four experimental cell groups. These were controls without added growth factors and cells supplemented with FGF-2, OP-1 or FGF-2/OP-1 combined. Cells were cultured 3, 5, 7, and 10 days (3 replicates/time point), counted and assayed by RT-qPCR to determine elastin and types II and III collagen gene expression.
[RESULTS] Compared to control counterparts, normal and microtia chondrocytes with OP-1 alone were similar in numbers and varied in elastin and types II and III collagen expression over all culture times. Compared to respective controls and chondrocyte groups with OP-1 alone, normal and microtia cell groups with FGF-2 had statistically significant (p<0.05) enhanced proliferation and statistically significant (p<0.05) decreased elastin and types II and III collagen expression over 10 days of culture.
[CONCLUSIONS] FGF-2 effects on normal and microtia chondrocytes support its use for increasing cell numbers while OP-1 maintains a chondrocyte phenotype, otherwise marked by increasing type III collagen expression and cellular dedifferentiation to fibroblasts in culture.
[METHODS] Two patients, one undergoing otoplasty and one an ear construction, yielded normal and microtia auricular chondrocytes, respectively. The two donor sets of isolated chondrocytes were equally divided into four experimental cell groups. These were controls without added growth factors and cells supplemented with FGF-2, OP-1 or FGF-2/OP-1 combined. Cells were cultured 3, 5, 7, and 10 days (3 replicates/time point), counted and assayed by RT-qPCR to determine elastin and types II and III collagen gene expression.
[RESULTS] Compared to control counterparts, normal and microtia chondrocytes with OP-1 alone were similar in numbers and varied in elastin and types II and III collagen expression over all culture times. Compared to respective controls and chondrocyte groups with OP-1 alone, normal and microtia cell groups with FGF-2 had statistically significant (p<0.05) enhanced proliferation and statistically significant (p<0.05) decreased elastin and types II and III collagen expression over 10 days of culture.
[CONCLUSIONS] FGF-2 effects on normal and microtia chondrocytes support its use for increasing cell numbers while OP-1 maintains a chondrocyte phenotype, otherwise marked by increasing type III collagen expression and cellular dedifferentiation to fibroblasts in culture.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | otoplasty
|
귀성형술 | dict | 1 | |
| 해부 | cartilage
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | ear
|
scispacy | 1 | ||
| 해부 | auricular chondrocytes
|
scispacy | 1 | ||
| 해부 | cellular
|
scispacy | 1 | ||
| 해부 | cells
|
scispacy | 1 | ||
| 해부 | chondrocytes
|
scispacy | 1 | ||
| 해부 | cell
|
scispacy | 1 | ||
| 해부 | elastin
|
scispacy | 1 | ||
| 해부 | types II
|
scispacy | 1 | ||
| 해부 | chondrocyte
|
scispacy | 1 | ||
| 해부 | fibroblasts
|
scispacy | 1 | ||
| 재료 | costal cartilage
|
늑연골 | dict | 1 | |
| 약물 | OP-1
→ osteogenic protein 1
|
C0083867
bone morphogenetic protein 7
|
scispacy | 1 | |
| 약물 | [CONCLUSIONS] FGF-2
|
scispacy | 1 | ||
| 질환 | Microtia
|
C0152423
Congenital small ears
|
scispacy | 1 | |
| 기타 | FGF-2
|
scispacy | 1 | ||
| 기타 | OP-1
→ osteogenic protein 1
|
scispacy | 1 | ||
| 기타 | auricular
|
scispacy | 1 | ||
| 기타 | basic fibroblast growth factor
|
scispacy | 1 | ||
| 기타 | human
|
scispacy | 1 | ||
| 기타 | collagen
|
scispacy | 1 | ||
| 기타 | type III collagen
|
scispacy | 1 |
MeSH Terms
Bone Morphogenetic Protein 7; Cell Differentiation; Cells, Cultured; Child; Chondrocytes; Congenital Abnormalities; Congenital Microtia; Ear; Ear Cartilage; Fibroblast Growth Factor 2; Humans; Male; Plastic Surgery Procedures; Reference Values; Tissue Donors; Tissue Engineering
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Otoplasty for prominent ear: A systematic review of surgical techniques.
- A comparative analysis of secondary unilateral and bilateral cleft lip nasal deformities: From anatomical characteristics to repair strategies.
- [Pressure ulcer following compression otoplasty garment: A rare but severe case report].
- Augmentation Rhinoplasty in Asian Patients.
- Iatrogenic pneumothorax associated with surgeries at anatomically thoracic-adjacent and non-adjacent sites: case report and scoping review.